sellWeak cluster of 410b5-1 plan
Karen M. Anderson sold $109k of CNTA
Chief People Officer at Centessa Pharmaceuticals plc. 6,471 shares at an average of $16.86, traded Feb 3, 2025, filed Feb 4, 2025.
Warning score
25Value
$109k
6,471 shares
Holdings after
54,322
-11% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +10Trade size$109k at market
- +5Share of holdings soldSold 11% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001847903-25-000026, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 1, 2025 | FTax withholding Ordinary Shares10b5-1 | -10,732 | $16.92 | $182k | 60,793 | Feb 4, 2025 |
| Feb 3, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -6,471 | $16.86 | $109k | 54,322 | Feb 4, 2025 |
| Feb 3, 2025 | AGrant or award Share Option (right to buy)derivative10b5-1 | +120,000 | $0.00 | $0 | 120,000 | Feb 4, 2025 |
Related signals
Other insiders at Centessa Pharmaceuticals plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $210k 15,000 shares | -6% | |
| 6Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $163k 10,000 shares | -7% | |
| 49Moderate | Centessa Pharmaceuticals plc | Saurabh Saha Chief Executive Officer | $918k 55,000 shares | -17% | |
| 5Weak | Centessa Pharmaceuticals plc | David M Chao Chief Administrative Officer | $120k 7,000 shares | -3% | |
| 5Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $99k 6,000 shares | -5% | |
| 22Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $175k 11,494 shares | -8% | |
| 48Moderate | Centessa Pharmaceuticals plc | Saurabh Saha Chief Executive Officer | $876k 55,000 shares | -14% | |
| 5Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $97k 6,000 shares | -5% | |
| 24Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $589k 30,955 shares | -36% | |
| 22Weak | Centessa Pharmaceuticals plc | Tia L Bush Chief Technology & Quality Ofc | $185k 11,000 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.